News Summary

FutureHouse, a nonprofit backed by Eric Schmidt, has introduced a new AI tool named Finch aimed at supporting data-driven discovery in biology. The tool processes biology data, primarily from research papers, to generate insights and figures. FutureHouse CEO Sam Rodriques likened Finch to a ‘first-year grad student’ due to its ability to quickly analyze data. Despite its potential, Finch is still in its early stages and subject to errors, prompting FutureHouse to recruit bioinformaticians and computational biologists for further development. The company joins other startups and tech giants in exploring AI for scientific advancements, specifically in drug discovery. However, many AI-driven efforts in this domain have faced challenges, including clinical trial failures.